Provided by Tiger Fintech (Singapore) Pte. Ltd.

PAVmed

0.5800
-0.0300-4.92%
Post-market: 0.59000.0100+1.72%19:04 EDT
Volume:152.76K
Turnover:91.72K
Market Cap:10.22M
PE:0.61
High:0.6300
Open:0.6300
Low:0.5800
Close:0.6100
Loading ...

Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

PR Newswire
·
03 Apr

Pavmed’s Strategic Growth and Financial Challenges

TIPRANKS
·
29 Mar

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology

PR Newswire
·
27 Mar

PAVmed Inc (PAVM) Q4 2024 Earnings Call Highlights: Strategic Growth and Financial Stability

GuruFocus.com
·
26 Mar

BRIEF-PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Reuters
·
25 Mar

PAVmed Inc: Qtrly EPS $0.12

THOMSON REUTERS
·
25 Mar

Lucid Diagnostics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
24 Mar

Lucid Diagnostics Inc: Qtrly Loss per Share $0.20

THOMSON REUTERS
·
24 Mar

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

THOMSON REUTERS
·
24 Mar

Press Release: Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Dow Jones
·
24 Mar

PAVmed Inc expected to post a loss of 57 cents a share - Earnings Preview

Reuters
·
22 Mar

Lucid Diagnostics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
21 Mar

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (Nccn) Guidelines NOW Include Esophageal Precancer Screening

THOMSON REUTERS
·
20 Mar

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening

PR Newswire
·
20 Mar

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

PR Newswire
·
18 Mar

PAVmed to Hold a Business Update Conference Call and Webcast on March 25, 2025

PR Newswire
·
11 Mar

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025

PR Newswire
·
10 Mar

BRIEF-Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

Reuters
·
06 Mar

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

THOMSON REUTERS
·
06 Mar

Lucid Diagnostics Prices $15.3 Million Direct Offering

MT Newswires Live
·
04 Mar